Eagle Pharmaceuticals, Inc. Press Releases

EGRX 
$80.7964
*  
5.3964
7.16%
Get EGRX Alerts
*Delayed - data as of Jun. 30, 2015 15:43 ET  -  Find a broker to begin trading EGRX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    EGRX Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By

Eagle Pharmaceuticals to Present at Cantor Fitzgerald Inaugural Healthcare Conference
6/30/2015 8:00:00 AM - Business Wire
▲11.52 % Price Change since this news event. The Volume Ratio is 0.92.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Eagle Pharmaceuticals Added to Russell 2000 Index
6/29/2015 8:00:00 AM - Business Wire
▼-1.91 % Price Change since this news event. The Volume Ratio is 1.33.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Eagle Pharmaceuticals to Present at Two Investor Conferences in June
5/21/2015 6:50:00 AM - Business Wire
▲31.18 % Price Change since this news event. The Volume Ratio is 2.26.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Eagle Pharmaceuticals Submits NDA for Ready-to-Use Bivalirudin to FDA
5/20/2015 6:50:00 AM - Business Wire
▲28.23 % Price Change since this news event. The Volume Ratio is 1.26.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


New Patent Issued for Eagle Pharmaceuticals’ Bendamustine Rapid Infusion Product
5/19/2015 8:30:00 AM - Business Wire
▲28.86 % Price Change since this news event. The Volume Ratio is 1.41.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Eagle Pharmaceuticals, Inc. Reports First Quarter 2015 Results
5/12/2015 6:50:00 AM - Business Wire
▲36.60 % Price Change since this news event. The Volume Ratio is 6.03.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day